Accuro 3S Diagnostic Ultrasound System
AI-powered portable ultrasound system for spinal needle guidance with dual-array probe technology
Device · On PremiseCompany source
Company profile
About Rivanna Medical
RIVANNA is a commercial-stage medical technology company headquartered in Charlottesville, Virginia, developing clinical decision-support solutions powered by proprietary clinical datasets, AI models, and purpose-built imaging hardware. The company's platform automates complex anatomical analysis at the point of care, enabling faster, more confident clinical decisions while reducing variability and expanding access to advanced capabilities. RIVANNA's first applications target significant market opportunities in regional anesthesia and fracture care. The company's flagship products include the Accuro 3S platform with SpineNav-AI software for spinal procedures and neuraxial anesthesia, and the Accuro XV system for musculoskeletal imaging and fracture detection. Both platforms leverage proprietary technologies including BoneEnhance Multi-Frequency Image Reconstruction for optimized bone visualization and automated image acquisition techniques. RIVANNA operates an FDA-registered, ISO 13485:2016-certified manufacturing facility and has built a strong intellectual property portfolio with over 100 issued and pending patents worldwide. The company serves healthcare providers in hospital and clinical settings, with a focus on anesthesiology, emergency medicine, and point-of-care diagnostics. RIVANNA's technology addresses longstanding challenges in ultrasound-guided procedures by enabling hands-free operation, automated anatomical landmark detection, and real-time needle guidance, making advanced imaging capabilities more accessible to clinicians.
Company description Rivanna Medical official website
Primary marketHealthcare Operations & Administration
Commercial modelCommercial information available on request
Company presenceX
Work at Rivanna Medical?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Blast-related injuries
- Epidural space visualization
- Extremity fractures
- Musculoskeletal injuries
- Neuraxial anesthesia procedures
- Regional anesthesia
- Spinal procedures
Who it serves
- Academic medical centers
- Anesthesiology departments
- Clinical settings
- Emergency departments
- Hospitals
Deployment & integration
Embedded · On Premise deployment with recorded integration context.
Recorded integration context: DICOM.
Geographic context
MarketsUnited States
Company sourceOfficial website
Company milestones
Platform expansion
FDA 510(k) clearance for Accuro 3S platform and SpineNav-AI software (July 2025). FDA 510(k) clearance for Accuro XV system (2026). Selected as MedTech Innovator 2025 Accelerator finalist (top 4% of 1,500 global applicants). Expanded clinical program to eight academic medical centers. 100th patent filing achieved (2026). BARDA partnership continuation for AI-powered fracture detection module.
Partnerships
Recorded partners
- BARDA (Biomedical Advanced Research and Development Authority)
- Duke University (exclusive patent license)
- Eight academic medical centers for clinical studies
- Tri-anim (U.S. distribution alliance)
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Accuro 3S Needle Guide Kit
Consumable probe cover and needle guide system for stabilized ultrasound-guided procedures
Device · On PremiseCompany source
Accuro XV Diagnostic Ultrasound System
AI-powered musculoskeletal imaging system for radiation-free fracture detection and triage
Device · On PremiseCompany source
SpineNav-AI Image Processing Software
Machine learning software for automated spinal anatomy detection and epidural space visualization
Software · EmbeddedCompany source
True-View
Ultrasound imaging product line for clinical applications
Device · On PremiseCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Feasibility of Spinal Anesthesia Placement Using Automated Interpretation of Lumbar Ultrasound Images: A Prospective Randomized Controlled Trial.Journal of anesthesia & clinical research · Jan 1, 2019
Imaging Performance of a Handheld Ultrasound System With Real-Time Computer-Aided Detection of Lumbar Spine Anatomy: A Feasibility Study.Investigative radiology · Aug 1, 2017
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
Accuro 3SK243937 · 510k · May 23, 2025
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
First-attempt success rates
Increased success rates in spinal procedures
Diagnostic quality imaging
Over 90% of scans by non-physician operators rated adequate after one hour of training
Fracture detection sensitivity and specificity
High sensitivity and specificity for detecting small fractures with BoneVision technology
Eight Academic Medical Centers (Multi-Site)
Multi-site clinical expansion for Accuro XV to build proprietary datasets for training automated fracture detection algorithms
Expanded clinical program from two to eight academic medical centers nationwide
University of Virginia (UVA)
Feasibility study demonstrating non-physician operators could acquire diagnostic-quality extremity images with minimal training using Accuro XV
Over 90% of scans rated adequate for diagnostic interpretation after just one hour of training
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Will Mauldin
Co-Founder & CEO
Vicki Brothers
Director of Marketing
06 · Company updates
Updates from Rivanna Medical
Recent articles published on Rivanna Medical's official website.
70 Birth Statistics and Facts
Read on Rivanna MedicalRIVANNA Has Anesthesiology’s Back in Epidural Injections
Read on Rivanna MedicalUsing AI to Strengthen Clinical Confidence: RIVANNA’s Will Mauldin on the Outcomes Rocket Podcast
Read on Rivanna Medical32% Cesarean Rate Drives Demand for First-Attempt Neuraxial Success
Read on Rivanna Medical07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Healthcare Operations & Administration
Companies using AI to optimize hospital operations, automate administrative workflows, improve scheduling, manage healthcare resources, coordinate care delivery, or reduce operational inefficiencies. Includes prior authorization automation, credentialing, billing, care coordination, and AI tools that help health systems run more efficiently.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.